Moderna, Inc. will get to see a dry run of how the US Food and Drug Administration’s advisory committee handles review of COVID-19 vaccine data as the firm prepares for its meeting before the panel.
FDA announced on 30 November that the Vaccines and Related Biological Products Advisory Committee (VRBAC) will meet 17 December to...







